Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancers (peritoneal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Talazoparib (talazoparib)
• ZEN003694

Snippet

Sponsor: Alexander B Olawaiye, MD | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: RECRUITING